Your browser doesn't support javascript.
loading
Retrospective analysis of the potential use of virtual control groups in preclinical toxicity assessment using the eTOX database.
Wright, Peter S R; Smith, Graham F; Briggs, Katharine A; Thomas, Robert; Maglennon, Gareth; Mikulskis, Paulius; Chapman, Melissa; Greene, Nigel; Phillips, Benjamin U; Bender, Andreas.
Afiliação
  • Wright PSR; University of Cambridge, Chemistry, Cambridge, United Kingdom. Electronic address: psrw2@cam.ac.uk.
  • Smith GF; AstraZeneca, Data Science and AI, Clinical Pharmacology and Safety Sciences, R&D, Cambridge, United Kingdom.
  • Briggs KA; Lhasa Limited, Leeds, United Kingdom.
  • Thomas R; Lhasa Limited, Leeds, United Kingdom.
  • Maglennon G; AstraZeneca, Oncology Pathology, Clinical Pharmacology and Safety Sciences, R&D, Melbourn, United Kingdom.
  • Mikulskis P; AstraZeneca, Imaging and Data Analytics, Clinical Pharmacology & Safety Sciences, R&D, Gothenburg, Sweden.
  • Chapman M; AstraZeneca, Toxicology, Clinical Pharmacology and Safety Sciences, R&D, Melbourn, United Kingdom.
  • Greene N; AstraZeneca, Imaging and Data Analytics, Clinical Pharmacology & Safety Sciences, R&D, Waltham, MA, USA.
  • Phillips BU; AstraZeneca, Data Sciences and Quantitative Biology, Discovery Sciences, Cambridge Biomedical Campus, Cambridge, United Kingdom.
  • Bender A; University of Cambridge, Chemistry, Cambridge, United Kingdom. Electronic address: andreas.bender@cantab.net.
Regul Toxicol Pharmacol ; 138: 105309, 2023 Feb.
Article em En | MEDLINE | ID: mdl-36481280
ABSTRACT
Virtual Control Groups (VCGs) based on Historical Control Data (HCD) in preclinical toxicity testing have the potential to reduce animal usage. As a case study we retrospectively analyzed the impact of replacing Concurrent Control Groups (CCGs) with VCGs on the treatment-relatedness of 28 selected histopathological findings reported in either rat or dog in the eTOX database. We developed a novel methodology whereby statistical predictions of treatment-relatedness using either CCGs or VCGs of varying covariate similarity to CCGs were compared to designations from original toxicologist reports; and changes in agreement were used to quantify changes in study outcomes. Generally, the best agreement was achieved when CCGs were replaced with VCGs with the highest level of similarity; the same species, strain, sex, administration route, and vehicle. For example, balanced accuracies for rat findings were 0.704 (predictions based on CCGs) vs. 0.702 (predictions based on VCGs). Moreover, we identified covariates which resulted in poorer identification of treatment-relatedness. This was related to an increasing incidence rate divergence in HCD relative to CCGs. Future databases which collect data at the individual animal level including study details such as animal age and testing facility are required to build adequate VCGs to accurately identify treatment-related effects.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Testes de Toxicidade Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Animals Idioma: En Revista: Regul Toxicol Pharmacol Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Testes de Toxicidade Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Animals Idioma: En Revista: Regul Toxicol Pharmacol Ano de publicação: 2023 Tipo de documento: Article